Turusbekova AK, Kalmatov RK, Moldoev M*, Zhanadilova GZH and Kalysbek KS

Department of Public Health, Osh State University, Kyrgyzstan

*Corresponding Author: Moldoev M, Department of Public Health, Osh State University, Kyrgyzstan.

Received: November 22, 2021; Published: December 29, 2021

Abstract

The study of the influence of the trophological status of patients on the course of pathologies of the gallbladder and stomach, physicochemical changes in bile and the state of the gastric mucosa can improve the results of treatment of combined pathologies of the hepatobiliary zone. The introduction into practice of gastroscopic studies of patients with cholelithiasis can substantiate the pathogenicity of the treatment of pathologies of neighboring organs.

Keywords: Organs; Gallbladder; Stomach

References

1. Kukosh МV and Vlasov AP. “Acute cholecystitis”. The science (2009).
2. Vahrushev YM and Hohlachev NA. “Cholelithiasis: epidemiology, risk factors, clinical features, prevention”. Archives of Internal Medicine29 (2016): 30-35.
3. Dadavani S. A. “Gallbladder disease”. Vidar-М (2000).
4. Gubergriss NB. “Gallbladder disease: from classic to modern times”. Gastroenterology (2010): 183-195.
5. Anisimova ЕV., et al. “Chronic cholecystitis in patients with different trophological status: mechanisms of occurrence and clinical features”. Russian Journal of Gastroenterology, Hepatology, Coloproctology 3 (2014): 36-41.
6. Luzina EV., et al. “Possible mechanisms of development of diseases of the biliary tract in the conditions of Transbaikalia”. Clinical Medicine 4 (2000): 34-36.
7. Brehov EI., et al. “Postoperative pancreatitis as one of the reasons for the development of postcholecystectomy syndrome”. Actual problems of hepatopancreatobiliary surgery: Materials of the XXI International Congress of the Association of Hepatopancreatobiliary Surgeons of the CIS countries.- Perm: ГБОУ ВПО ПГМА имени академика Е.А. Вагнера Минздрава России (2014): 145.
8. SN Styazhkina., et al. “Ayupov Chronic calculous cholecystitis is an actual socio-economic disease”. Journal of Scientific Articles.
9. Dobrovolskiy SR., et al. “Results of using different cholecystectomy options in patients of older age groups”. Surgery. Notes N.I. Pirogova 9 (2011): 11-14.
10. Dorofeev OV., et al. “Nutritional support in the perioperative period in patients with destructive cholecystitis”. Russian Open Medical Journal 1 (2010): 19-22.
11. Bradea C., et al. “Laparoscopic cholecystectomy in non-lithiasis cholecystopathies. Colecistectomialaparoscopica in colecistopatiilenelitiazice”. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 4 (2000): 91-93.
12. Krivosheev AB., et al. “Non-alcoholic fatty liver disease in the elderly”. Experimental and Clinical Gastroenterology9 (2016): 2711-2731.
13. Lazebnik LB., et al. “Non-alcoholic fatty liver disease: clinical picture, diagnosis, treatment (recommendations for therapists-2nd eddition)”. Experimental and Clinical Gastroenterology2 (2017): 22-37.
14. Efimenko NA. “Surgical tactics for the treatment of complicated forms of gallstone disease in elderly and senile people”. 3 (2011): 48-52.
15. Jolnerchik A Y. “Change in the age-sex structure of the group of patients who underwent cholecystectomy at the turn of the XX-XXI centuries”. 6.5 (2016): 1063.
16. Kotelnikova LP., et al. “Lipid metabolism disorders and morphological changes in the liver in patients with extreme obesity”. Experimental and Clinical Gastroenterology6 (2016): 48-51.
17. Saveliev VS., et al. “Lipid Distress Syndrome. A guide for doctors”. 3^rd edition МаксПресс, (2010): 600.
18. Hohlacheva NA., et al. “Age and gender characteristics of the development of gallstone disease”. Archives of Internal Medicine1 (2016): 34-39.
19. Duncan CB., et al. “Evidence-based current surgical practice: calculous gallbladder disease”. Journal of Gastrointestinal Surgery 11 (2012): 2011-2025.
20. Sherlok Sh. “Diseases of the liver and biliary tract”. Изд. Дом ГЭОТАР-МЕД, (2002): 859.
21. Chen L., et al. “Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review”. World Journal of Clinical Cases 7 (2015): 599 -606.
22. Laura M., et al. “Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer”. Gut and Liver 2. (2012): 172 -187.
23. Fracanzani AL., et al. “Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease”. PLoS One7 (2012): 1183.
24. Koebnick C., et al. “Pediatric obesity and gallstone disease”. Journal of Pediatric Gastroenterology and Nutrition3 (2012): 328-333.
25. Baykova OA., et al. “Clinical and functional manifestations of biliary dyskinesias in women”. Topical issues of biomedical and clinical anthropology, Material Science conference Krasnoyarsk 117-118.
26. Grigor'eva IN., et al. “Frequency combination of a gallstone disease and diabetes”.
27. Klin Gastroenterol Journal 4 (2011): 99-102.
28. Khan MH., et al. “Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center”. Klin Gastroenterol Journal 2 (2007): 247-252.
29. Liew PL., et al. “Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity”. Obesity Surgery7 (2008): 847-853.
30. Bonfrate L., et al. “Obesity and the risk and prognosis of gallstone disease and pancreatitis”. Best Practice and Research Clinical Gastroenterology 4 (2014): 623-635.
31. Reshetnyak VI. “Concept of the pathogenesis and treatment of cholelithiasis. World Journal of Hepatology 2 (2012): 18-34.
32. Scollay JM., et al. “Mortality associated with the treatment of gallstone disease: a 10- year contemporary national experience”. World Journal of Surgery 3 (2011): 643-647.
33. Skouras C., et al. “Is early laparoscopic cholecystectomy for acute cholecystitis preferable to delayed surgery? Best evidence topic (BET)”. International Journal of Surgery 5 (2012): 250-258.
34. Portincasa P., et al. “Therapy of gallstone disease: What it was, what it is, what it will be”. World Journal of Gastrointestinal Pharmacology and Therapeutics2 (2012): 7-20.
35. Qin J., et al. “Study on the characteristics of inheritance and epidemiology in one pedigree with gallstone disease. Zhonghua Liu Xing Bing Xue Za Zhi 26.6 (2005): 448-450.
36. Sonne DP., et al. “Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion”. European Journal of Endocrinology2 (2014): 47-65.
37. Gulubov VV., et al. “Endocrine cells in the human common bile duct in patients with obstructive jaundice”. Hepatogastroenterology113 (2012): 26-30.
38. Sodhi JS., et al. “Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: A case control study”. Indian Journal of Gastroenterology 6 (2014): 507-511.
39. Alawneh I. “Acute noncalculous Cholecystitis in Burns”. Brit. J. / Surg.-1978.-№4.-P.243-245.
40. Stinton LM., et al. “Epidemiology of Gallbladder Disease: Cholelithiasis and cancer”. Gut and Liver 2 (2012): 172-187.
41. Wang W., et al. “The Association of Gallstone Disease and Diabetes Mellitus”. Saudi Medical Journal 9 (2014): 1005-1012.
42. Zhang Y., et al. “Endoscopic-Laparoscopic cholecystolithotomy in treatment of cholecystolithiasis compared with traditional laparoscopic cholecystectomy”. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 5 (2016): 377-380.
43. Parmeggiani D., et al. “Biliary tract injuries during laparoscopic cholecystectomy: three case reports and literature review”. Giornale di chirurgia 1-2 (2016): 16-19.
44. Pradhan G., et al. “Ghrelin: much more than a hunger hormone”. Current Opinion in Clinical Nutrition and Metabolic Care 6 (2013): 619-624.
45. Glenn F., “Epidemiology of gallstone disease”. Gastroenterology 79 (1978): 76-80.
46. Yoo EH., et al. “The prevalence and risk factors for gallstone disease”. Clinical Chemistry and Laboratory Medicine 7 (2009): 795-807.
47. “Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations”. Advances in Aging Research 5 (2016): 9-26.
48. “Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome”. Journal of Clinical Epigenetics 3 (2017): 24.
49. “Nutrition Therapy Regulates Caffeine Metabolism with Relevance to NAFLD and Induction of Type 3 Diabetes”. Journal of Diabetes and Metabolic Disorders 4 (2017): 019.

Citation

Citation: Moldoev M., et al. “Morphofunctional Relationship of Gallbladder Pathology with Stomach Pathology in the Conditions of Kara-Suu General Practice Centers. Influence of the Trophological Status to Stone Formation". Acta Scientific Gastrointestinal Disorders 5.1 (2022): 49-56.

Copyright

Copyright: © 2022 Moldoev M., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.